Precigen (PGEN) Operating Leases (2019 - 2026)
Precigen (PGEN) reported Operating Leases of $4.7 million for Q1 2026, up 5.39% year-over-year from $4.5 million in Q1 2025, and up 18.87% quarter-over-quarter from $4.0 million in Q4 2025.
Precigen (PGEN) Operating Leases (2019 - 2026) Analysis & Trends
Precigen (PGEN) has 8 years of Operating Leases data on file, last reported at $4.7 million in Q1 2026.
- Operating Leases for Q1 2026 came in at $4.7 million, up 5.39% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.7 million (up 5.39% YoY), and the FY2025 annual result was $4.0 million, down 12.45% from the prior year.
- Operating Leases advanced to $4.7 million in Q1 2026 per PGEN's latest filing, from $4.0 million in the prior quarter.
- Over five years, Operating Leases peaked at $9.5 million in Q1 2022 and troughed at $4.0 million in Q4 2025.
- A 5-year average of $6.2 million and a median of $6.2 million in 2023 frame the typical range for Operating Leases.
- The sharpest annual moves came in 2022 and 2025: Operating Leases soared 36.94% in 2022, then plunged 33.05% in 2025.
- A 5-year view of Operating Leases shows it stood at $7.0 million in 2022, then slipped by 15.69% to $5.9 million in 2023, then retreated by 22.88% to $4.5 million in 2024, then retreated by 12.45% to $4.0 million in 2025, then grew by 18.87% to $4.7 million in 2026.
- Business Quant data shows PGEN's Operating Leases at $4.7 million in Q1 2026, $4.0 million in Q4 2025, and $5.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Precigen | 1.27 Bn | 1.27 Bn | 20.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.73 Mn |
| Dec 31, 2025 | 3.98 Mn |
| Sep 30, 2025 | 5.30 Mn |
| Jun 30, 2025 | 5.15 Mn |
| Mar 31, 2025 | 4.49 Mn |
| Dec 31, 2024 | 4.55 Mn |
| Sep 30, 2024 | 4.76 Mn |
| Jun 30, 2024 | 6.34 Mn |
| Mar 31, 2024 | 6.71 Mn |
| Dec 31, 2023 | 5.90 Mn |
| Sep 30, 2023 | 6.19 Mn |
| Jun 30, 2023 | 6.55 Mn |
| Mar 31, 2023 | 6.62 Mn |
| Dec 31, 2022 | 6.99 Mn |
| Sep 30, 2022 | 8.98 Mn |
| Jun 30, 2022 | 9.13 Mn |
| Mar 31, 2022 | 9.51 Mn |
| Dec 31, 2021 | 8.75 Mn |
| Sep 30, 2021 | 11.20 Mn |
| Jun 30, 2021 | 11.82 Mn |